BRCA2 and breast carcinoma: It is appropriate that the recently released American Society of Clinical Oncology/Surgical Society of Oncology genetic testing guidelines endorse germline testing for BRCA1 and BRCA2 in all newly diagnosed women with breast cancer who are younger than age of 65 years.